Laurus Labs Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,778.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.55 per cent from ₹1,653.47 crore. This corresponds to a year-on-year *(YoY) growth of 25.67 per cent.
Operating Profit
Operating Profit stands at ₹480.21 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.08 per cent from ₹403.26 crore. This corresponds to a year-on-year *(YoY) growth of 68.41 per cent.
PBDT
PBDT stands at ₹445.95 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.07 per cent from ₹390.96 crore. This corresponds to a year-on-year *(YoY) growth of 86.51 per cent.
Profit Before Tax
Profit Before Tax stands at ₹325.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.28 per cent from ₹270.47 crore. This corresponds to a year-on-year *(YoY) growth of 144.59 per cent.
Net Profit
Net Profit stands at ₹251.88 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.51 per cent from ₹194.49 crore. This represents a 171.01 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Laurus Labs Ltd News
Laurus Labs Ltd Earnings
- YOY
- QOQ
Laurus Labs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Laurus Labs Ltd Research Reports
Laurus Labs Ltd Financial Reports
Laurus Labs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Laurus Labs | -2.77% | -3.18% | 10.19% | 13.24% | 12.67% | 81.00% |
| Aurobindo Pharma | 0.45% | -1.02% | 9.06% | 17.24% | 28.92% | 15.61% |
| Glenmark Pharma. | 3.53% | 2.90% | 12.73% | 19.24% | 27.68% | 74.20% |
| Alkem Lab | 1.36% | -1.88% | 2.06% | -4.59% | -2.01% | 5.89% |
| Biocon | 0.41% | 1.59% | 0.73% | -0.83% | -3.58% | 12.99% |
| Abbott India | -0.76% | -0.64% | -2.56% | -8.73% | -14.76% | -15.45% |
| Anthem Bioscienc | 0.35% | 4.48% | 17.89% | 29.26% | 7.86% | 5.94% |
Company Info
Company Information
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru